As of 2025-04-18, the Relative Valuation of Passage Bio Inc (PASG) is (34.91) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.33 USD, the upside of Passage Bio Inc based on Relative Valuation is -10679.0%.
The range of the Relative Valuation is (28.66) - (34.41) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.5x - 40.6x | 36.5x |
| Forward P/E multiples | 23.5x - 33.0x | 30.5x |
| Fair Price | (28.66) - (34.41) | (34.91) |
| Upside | -8784.2% - -10527.4% | -10679.0% |
| Date | P/E |
| 2025-04-15 | -0.35 |
| 2025-04-14 | -0.37 |
| 2025-04-11 | -0.35 |
| 2025-04-10 | -0.35 |
| 2025-04-09 | -0.39 |
| 2025-04-08 | -0.31 |
| 2025-04-07 | -0.34 |
| 2025-04-04 | -0.33 |
| 2025-04-03 | -0.34 |
| 2025-04-02 | -0.38 |
| 2025-04-01 | -0.37 |
| 2025-03-31 | -0.34 |
| 2025-03-28 | -0.37 |
| 2025-03-27 | -0.40 |
| 2025-03-26 | -0.44 |
| 2025-03-25 | -0.47 |
| 2025-03-24 | -0.48 |
| 2025-03-21 | -0.48 |
| 2025-03-20 | -0.46 |
| 2025-03-19 | -0.45 |
| 2025-03-18 | -0.43 |
| 2025-03-17 | -0.37 |
| 2025-03-14 | -0.37 |
| 2025-03-13 | -0.38 |
| 2025-03-12 | -0.38 |
| 2025-03-11 | -0.40 |
| 2025-03-10 | -0.39 |
| 2025-03-07 | -0.44 |
| 2025-03-06 | -0.45 |
| 2025-03-05 | -0.45 |
| 2025-03-04 | -0.41 |
| 2025-03-03 | -0.46 |
| 2025-02-28 | -0.50 |
| 2025-02-27 | -0.49 |
| 2025-02-26 | -0.49 |
| 2025-02-25 | -0.51 |
| 2025-02-24 | -0.50 |
| 2025-02-21 | -0.50 |
| 2025-02-20 | -0.53 |
| 2025-02-19 | -0.52 |
| 2025-02-18 | -0.53 |
| 2025-02-14 | -0.54 |
| 2025-02-13 | -0.50 |
| 2025-02-12 | -0.50 |
| 2025-02-11 | -0.51 |
| 2025-02-10 | -0.55 |
| 2025-02-07 | -0.57 |
| 2025-02-06 | -0.56 |
| 2025-02-05 | -0.57 |
| 2025-02-04 | -0.59 |